Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISLB 2022 | Unmet needs in lung cancer from a patient perspective

Amy Moore • 24 Oct 2022
ISLB 2022
Lung Cancer

Amy Moore, PhD, Lungevity Foundation, USA, discusses the importance of widening access to new effective therapies across the world, and strategies to achieve this. This interview took place at the International Society of Liquid Biopsy (ISLB) 2022 congress in Miami, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Advisory Board: Bayer, Pfizer, Novartis, Exact Sciences, Jazz Pharmaceuticals, Debiopharm

More from Amy Moore

2:39
Current challenges for lung cancer patients due to COVID-19
Amy Moore • 24 Oct 2022
4:46
Challenges to be overcome in liquid biopsy
Amy Moore • 24 Oct 2022
3:35
Impact of COVID-19 on lung cancer diagnosis and treatment
Amy Moore • 18 Oct 2021
2:13
Future directions for lung cancer research
Amy Moore • 18 Oct 2021

Related Videos

0:37
STABLE-MATES: sublobar resection vs SAbR in high-risk patients with stage I NSCLC
Clive Peedell • 18 Apr 2024
0:44
BTOG 2024: networking highlights and insights
Clive Peedell • 18 Apr 2024
0:49
Ongoing trials in thoracic radiotherapy: evaluating current role and significance
Thomas Newsom-Davis • 18 Apr 2024
4:20
Insights from BTOG 2024: advancements in TNM Staging, systematic staging, & immunotherapy strategies
Thomas Newsom-Davis • 18 Apr 2024
The content of VJOncology is intended for healthcare professionals